Literature DB >> 19284932

Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.

Teresa Lanza di Scalea1, Barbara H Hanusa, Katherine L Wisner.   

Abstract

OBJECTIVE: The primary aim of this article is to describe sexual concerns in postpartum women with DSM-IV diagnoses of major depressive disorder (MDD) before and during treatment with antidepressants in an 8-week double-blind randomized trial.
METHOD: Seventy women aged 19-42 years participated and were randomly assigned to either the tricyclic antidepressant nortriptyline (N = 38) or the serotonin selective reuptake inhibitor sertraline (N = 32). Women completed the Arizona Sexual Experience Scale to evaluate sexual concerns at enrollment and weekly during the trial. The outcome measure for depression, Hamilton Rating Scale for Depression, was completed in clinical interviews at the same time points. Comparisons of demographic and other characteristics of women were completed with t tests for continuous measures and with chi-squared or Fisher exact statistics for categorical measures. Mixed-effects regressions were used to test for significance of the main effects of depression symptom scores, drug assignment, weeks treated with medication, and the interactions of these variables. Data were collected from April 1997 to April 2002.
RESULTS: At entry into the randomized trial, 73% (N = 51) of the women reported problems in 3 or more areas of sexual concern compared to 37% (N = 26) at week 8. There were no significant differences at study entry in women randomly assigned to nortriptyline compared to those randomly assigned to sertraline in summary scores of sexual function nor in specific sexual concerns at any time point. At week 8, women whose MDD remitted were more likely to report fewer (< 3) sexual concerns than women whose MDD did not remit (76% vs. 24%, p = .006), independent of drug assignment.
CONCLUSIONS: In postpartum women, sexual concerns are primarily affected by remission of depression rather than side effects of either a tricyclic or serotonergic antidepressant. ©Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19284932      PMCID: PMC7081840          DOI: 10.4088/jcp.08m04625

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  34 in total

1.  Sexuality during pregnancy and after childbirth: a metacontent analysis of 59 studies.

Authors:  K von Sydow
Journal:  J Psychosom Res       Date:  1999-07       Impact factor: 3.006

Review 2.  [Depression and sexual disorders].

Authors:  F Ducrocq
Journal:  Encephale       Date:  1999 Sep-Oct       Impact factor: 1.291

3.  Sexual dysfunction before antidepressant therapy in major depression.

Authors:  S H Kennedy; S E Dickens; B S Eisfeld; R M Bagby
Journal:  J Affect Disord       Date:  1999-12       Impact factor: 4.839

Review 4.  Effects of SSRIs on sexual function: a critical review.

Authors:  R C Rosen; R M Lane; M Menza
Journal:  J Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.153

5.  Postpartum sexual functioning and its relationship to perineal trauma: a retrospective cohort study of primiparous women.

Authors:  L B Signorello; B L Harlow; A K Chekos; J T Repke
Journal:  Am J Obstet Gynecol       Date:  2001-04       Impact factor: 8.661

6.  Psychological factors and the sexuality of pregnant and postpartum women.

Authors:  Margaret A DeJudicibus; Marita P McCabe
Journal:  J Sex Res       Date:  2002-05

Review 7.  Clinical issues in long-term treatment with antidepressants.

Authors:  J M Zajecka
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

8.  Barriers to treatment among members of a mental health advocacy group in South Africa.

Authors:  S Seedat; D J Stein; M Berk; Z Wilson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2002-10       Impact factor: 4.328

9.  Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.

Authors:  John Zajecka; David L Dunner; Alan J Gelenberg; Robert M A Hirschfeld; Susan G Kornstein; Philip T Ninan; A John Rush; Michael E Thase; Madhukar H Trivedi; Bruce A Arnow; Frances E Borian; Rachel Manber; Martin B Keller
Journal:  J Clin Psychiatry       Date:  2002-08       Impact factor: 4.384

10.  The nature of sexual desire: a clinician's perspective.

Authors:  Stephen B Levine
Journal:  Arch Sex Behav       Date:  2003-06
View more
  5 in total

Review 1.  Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Meta-Analysis of Pharmacotherapy.

Authors:  Meera Viswanathan; Jennifer Cook Middleton; Alison M Stuebe; Nancy D Berkman; Alison N Goulding; Skyler McLaurin-Jiang; Andrea B Dotson; Manny Coker-Schwimmer; Claire Baker; Christiane E Voisin; Carla Bann; Bradley N Gaynes
Journal:  Psychiatr Res Clin Pract       Date:  2021-05-04

Review 2.  Development of neuroactive steroids for the treatment of postpartum depression.

Authors:  Handan Gunduz-Bruce; Koji Takahashi; Ming-Yi Huang
Journal:  J Neuroendocrinol       Date:  2021-08-30       Impact factor: 3.870

3.  Treatment of postpartum depression: clinical, psychological and pharmacological options.

Authors:  Elizabeth Fitelson; Sarah Kim; Allison Scott Baker; Kristin Leight
Journal:  Int J Womens Health       Date:  2010-12-30

4.  Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

Authors:  Jana Strohmaier; Stefan Wüst; Rudolf Uher; Neven Henigsberg; Ole Mors; Joanna Hauser; Daniel Souery; Astrid Zobel; Mojca Z Dernovsek; Fabian Streit; Christine Schmäl; Dejan Kozel; Anna Placentino; Anne Farmer; Peter McGuffin; Katherine J Aitchison; Marcella Rietschel
Journal:  World J Biol Psychiatry       Date:  2011-03-09       Impact factor: 4.132

5.  Antidepressant treatment for postnatal depression.

Authors:  Jennifer Valeska Elli Brown; Claire A Wilson; Karyn Ayre; Lindsay Robertson; Emily South; Emma Molyneaux; Kylee Trevillion; Louise M Howard; Hind Khalifeh
Journal:  Cochrane Database Syst Rev       Date:  2021-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.